Related Experiment Video
Updated: Jun 18, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Patient readiness to adhere to HAART
Richard M Grimes1, Deanna E Grimes
1Department of Internal Medicine, Medical School, The University of Texas Health Science Center, Houston, Texas, USA. richard.m.grimes@uth.tmc.edu
Objectives:
To determine 1) whether patients' statements of readiness to take HAART predicted adherence and 2) whether previous experience with HAART enabled patients to better predict adherence.
Method:
Thirty-nine patients (24 naïve to HAART and 15 reinitiating HAART after a hiatus of >6 months) indicated readiness to take HAART on a Likert scale and a visual analog scale (VAS). Adherence was measured by prescription renewals.
Results:
Participants were 72% male; 62% African/American; 23% Anglo-White, and 13% Hispanic. Patients considered themselves quite ready to initiate therapy on both scales. Adherence for 5 months ranged from 24% to 100%; mean = 68%; median = 78%. Adherence was not associated with readiness as measured by the Likert scale (F = .15, p = .86) or the VAS (r = -.078, p = .64). VAS readiness scores did not correlate with adherence for naïve (r = -.16; p = .47) or experienced (r = .09; p = .76) patients.
Conclusions:
Patients' statements of readiness to take HAART do not predict their adherence.
Related Concept Videos
Retrovirus Life Cycles
Sexually Transmitted Infections
Kidney Transplant III: Nursing Management
Therapeutic Drug Monitoring: Affecting Factors
Drug Therapy
Antianxiety Medications
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...

